{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Austria Specialty Business Services news", "home_page_url": "https://sharemaestro.com/newsreel/at/industrials/specialty-business-services/", "feed_url": "https://sharemaestro.com/newsreel/at/industrials/specialty-business-services/feed.json", "description": "Latest Specialty Business Services company headlines from Austria, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:5f3ffd7b43db74effa140b90ac2ade224c7ea21f9322104f94b219d7d32d8cf0", "url": "https://finance.yahoo.com/markets/stocks/articles/iss-wbo-iss-h1-2026-010816868.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/iss-wbo-iss-h1-2026-010816868.html", "title": "ISS AS (WBO:ISS) (H1 2026) Earnings Call Highlights: Strong Organic Growth and Strategic Wins ...", "content_text": "This article first appeared on GuruFocus. Revenue: Increased by DKK3 billion compared with the first half of 2025. Organic Growth: 8.9% in the second quarter, with a like-for-like contribution of 2% for the third consecutive quarter. Operating Margin: 4.6% for the first half of 2026. Free Cash Flow: DKK600 million for the first half of 2026, including a DKK600 million one-time payment from Deutsche Telekom. Earnings Per Share: Improved by 29% compared with the first half of 2025. Retention Rate: Improved to 95%. Contract Maturity Profile: Remained at 1% for 2026. Regional Organic Growth (Q2): Northern Europe 4%, Central and Southern Europe 18%, Asia Pacific 6%, Americas negatively impacted by contract exits in Chile. Above-Base Revenue: 3% in the second quarter, driven by strong performance across European regions and a one-off from DTAG. Share Buyback Program: Increased to DKK3.1 billion following the Deutsche Telekom settlement. Dividend: Approximately DKK500 million paid in April, corresponding to DKK3.2 per share. Share Count: Reduced to 160 million following the cancellation of 14.2 million shares. Full Year 2026 Guidance: Organic growth above 6%, operating margin around 5.25%, cash conversion above 60%, and free cash flow above DKK3.1 billion. Warning! GuruFocus has detected 2 Warning Sign with BOM:531358. Is WBO:ISS fairly valued? Test your thesis with our free DCF calculator. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points ISS AS (WBO:ISS) delivered strong organic growth of 8.9% in Q2 2026, with a like-for-like contribution of 2% for the third consecutive quarter, indicating improved growth quality. The company improved its operating margin to 4.6% in H1 2026, driven by operational improvements and the Deutsche Telekom settlement, which is expected to add 10-15 basis points annually. Free cash flow turned positive at DKK600 million in H1, benefiting from the DTAG settlement payment and improved working capital management. Commercial momentum strengthened with a retention rate of 95% and 10 positive contract changes year-to-date, including key wins like DWP, COWI, and Velux. The Deutsche Telekom contract was extended by 6 years to 2035, providing long-term visibility and a stronger partnership foundation. The acquisition of Toma was completed and integrated successfully, adding over 4,000 employees and strengthening the Nordic position. Capital returns to shareholders are robust, with a dividend and share buyback program yielding 8%, and a share count reduction of over 8% in 2026. Story Continues Negative Points Organic growth in the Americas was negatively impacted by net new wins, primarily due to smaller contract exits in Chile, and the US growth was flat. The Americas margin was pressured by targeted commercial investments in the US and restructuring costs in Chile, with no immediate recovery expected in H2. Northern Europe experienced negative volume and net new contributions in Q2 due to contract losses and scope reductions, though Q3 is expected to improve. Asia Pacific margins were impacted by legal costs related to the Hong Kong Wang Fuk Court fire, though these are not expected to repeat at the same magnitude in H2. The company's guidance for organic growth of above 6% was not raised despite strong Q2, citing tough comparables in Q4 and uncertainty in above-base activity. The DTAG settlement's one-off revenue is not a full drop-through to profit, as costs will offset it over the year, limiting the immediate earnings impact. Q & A Highlights Q: Why hasn't the company raised its full-year organic growth guidance further, given the strong Q2 print of 8.9% and the implied lower growth in H2? Also, why was the free cash flow guidance upgrade in May only related to the Deutsche Telekom payment and not the improved operating performance?A: CFO Mads Holm explained that it is \"a little bit of a notch too early\" to raise g", "date_published": "2026-08-13T01:08:16+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "ISS"], "_sharemaestro": {"country": "Austria", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ISS", "name": "ISS A/S", "sentiment_url": "https://sharemaestro.com/sentiment/3d13a599-1fe5-4207-9bf2-3d43f38564fe/"}]}}, {"id": "source:83f4575efeddc7906f57335c4acbe130e39d95c0be7a407506a25e7db1abf8e4", "url": "https://finance.yahoo.com/healthcare/articles/wolters-kluwer-brings-trusted-medi-133000317.html", "external_url": "https://finance.yahoo.com/healthcare/articles/wolters-kluwer-brings-trusted-medi-133000317.html", "title": "Wolters Kluwer Brings Trusted Medi-Span Medication Intelligence to Growing Veterinary Drug Market", "content_text": "WK survey finds three out of four pet owners want pet prescriptions from their retail pharmacy, creating new growth opportunities for pharmacies and pharmacy technology providers WALTHAM, Mass., August 11, 2026--(BUSINESS WIRE)--Wolters Kluwer Health today announced the availability of Medi-Span\u00ae Vet Meds, an embedded drug data and screening solution to help U.S. pharmacies seamlessly expand to serve pet owners by providing veterinary prescriptions at the same place where they pick up their own medications. Built specifically for retail pharmacies, pharmacy partners, and veterinary medication fulfillment organizations, the solution powers animal-specific medication screening at scale for greater consistency, efficiency, and safety. Pet parents want convenience and safety with pet medicines A new Wolters Kluwer survey of U.S. pet owners* points to a clear opportunity for pharmacies expanding into veterinary prescriptions. While 75% of consumers surveyed would like to fill pet prescriptions through the same channels they use for family medications, 80% say pharmacists having access to pet-specific medication safety information is important. Evolving to capture a growing veterinary medicine market As veterinary medications move into retail pharmacy, fulfillment, and digital pet medication channels, many dispensing systems are still built only for human medications. As a result, veterinary prescriptions often require pharmacists to rely on manual references or screening tools designed for human medications. These gaps can pull pharmacists out of their usual workflow, increasing the potential for inconsistencies and clinical risk, especially as animal prescription volumes grow. \"For decades, healthcare organizations have relied on Medi-Span for trusted medication intelligence that supports efficient medication decision-making,\" said Chris Sullivan, Vice President and General Manager, Pharmacy and Health Technology Solutions, Wolters Kluwer Health. \"Medi-Span Vet Meds extends that trusted foundation into veterinary care, helping pharmacies expand into a growing market with purpose-built medication intelligence designed specifically for veterinary prescribing and dispensing.\" What sets Medi-Span pet medication resources apart? The Medi-Span suite of drug databases and APIs has been trusted across the healthcare ecosystem for over 50 years to efficiently and dependably support medication-related decision-making, support compliance, and drive scalable digital health tech innovation. Medi-Span Vet Meds uses structured, machine-readable veterinary drug data and species-specific screening rules that account for differences in dosing ranges, toxicities, contraindications, and drug interactions across animal species. Supported by Medi-Span's governed clinical data stewardship processes, the solution delivers repeatable screening designed for enterprise dispensing environments. Story Continues Learn more about Medi-Span Vet Meds. *This survey, conducted by Wolters Kluwer in July 2026, is among 2,000 adults who are U.S. adults, 18 and older, and is weighted by age, gender, household income, region and education to be representative of the total U.S. population according to the U.S. Census Bureau, of whom 1,336 are pet owners. About Wolters Kluwer Wolters Kluwer (EURONEXT: WKL) is a global leader in information solutions, software and services for professionals in healthcare, tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Wolters Kluwer reported 2025 annual revenues of \u20ac6.1 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,100 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Eurone", "date_published": "2026-08-11T13:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "WKL"], "_sharemaestro": {"country": "Austria", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WKL", "name": "Wolters Kluwer N.V.", "sentiment_url": "https://sharemaestro.com/sentiment/50731efd-0c9a-451d-8506-95bc38ea6fbe/"}]}}, {"id": "source:669d5c8f5a066fb7033292160d75f092103f7f404840e861346eff829ea9c72a", "url": "https://finance.yahoo.com/technology/articles/wolters-kluwer-enables-longcheer-drive-130000566.html", "external_url": "https://finance.yahoo.com/technology/articles/wolters-kluwer-enables-longcheer-drive-130000566.html", "title": "Wolters Kluwer Enables Longcheer to Drive Finance Transformation With CCH Tagetik", "content_text": "CCH Tagetik accelerates financial close by 33%, reduces manual workload by 80%, and enables end\u2011to\u2011end strategy\u2011to\u2011execution performance management MUMBAI, India, August 11, 2026--(BUSINESS WIRE)--Wolters Kluwer, a global leader in professional information, software solutions and services, today announced the successful go live of the CCH\u00ae Tagetik Corporate Performance Management (CPM) platform at Longcheer, a global leader in intelligent products and services. The implementation establishes a unified, finance driven digital platform spanning group consolidation, financial planning and analysis (FP&A), and management reporting, enabling Longcheer to transition from fragmented, manual processes to an integrated, intelligent operating model that supports faster decision making and stronger governance. Addressing complexity with a unified CPM platform As a rapidly expanding, dual-listed global enterprise on A-share and H-share markets, operating across 40 legal entities and multiple geographies, Longcheer faced increasing complexity in financial consolidation, data management and operational analysis. Disconnected systems, manual processes and evolving compliance requirements limited efficiency and visibility. Wolters Kluwer implemented CCH Tagetik to unify financial data, standardize processes and support multi\u2011GAAP reporting (IFRS and local standards) within a single, scalable platform. The solution integrates data across systems and enables real\u2011time access to consistent, reliable financial insights. Delivering measurable impact across finance operations With CCH Tagetik fully deployed, Longcheer has achieved significant, quantifiable results: 33% faster financial close, reducing cycle time from 6 to 4 days 80% reduction in manual consolidation workload, improving accuracy and efficiency Real\u2011time management reporting, eliminating reporting delays and data inconsistencies ~10% improvement in forecast accuracy through rolling forecasts and scenario modeling Full compliance with IFRS and local GAAP, supporting dual\u2011listing requirements These improvements provide a strong foundation for data\u2011driven decision\u2011making, enhanced audit readiness, and enterprise\u2011wide performance visibility. Enabling strategy\u2011to\u2011execution performance management Beyond close and reporting, CCH Tagetik enables Longcheer to connect strategic planning, budgeting, forecasting and operational execution within a single platform. Through advanced modeling and scenario simulation, management can assess the financial impact of market changes, such as price fluctuations, FX movements and supply chain dynamics, in real time. Story Continues Michael Chung, General Manager of CCH Tagetik Greater China at Wolters Kluwer, said: \"Longcheer's transformation highlights how finance can evolve from a transactional function into a strategic driver of value. With CCH Tagetik, the organization now has a unified, trusted data foundation that supports faster close cycles, deeper insights and a true end to end 'strategy to execution' management approach.\" Zhen Zhen Wu, Financial Director from Longcheer added: \"As our business expanded, we faced growing challenges in budgeting, forecasting and operational analysis. With CCH Tagetik, we've built an end\u2011to\u2011end finance platform that connects strategy to execution, transforming financial data into forward\u2011looking insight and enabling stronger control, visibility and sustainable global growth.\" Longcheer now has a unified CPM foundation in place. Moving forward, Wolters Kluwer will extend CPM capabilities, including deeper analytical use cases, enhanced profitability analysis and the exploration of AI-driven insights to further strengthen decision-making and operational agility. A full case study about Longcheer's successful implementation of the CCH Tagetik is available. About Wolters Kluwer Wolters Kluwer (EURONEXT: WKL) is a global leader in information solutions, software and services for professionals in healthcare; tax and account", "date_published": "2026-08-11T13:00:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "WKL"], "_sharemaestro": {"country": "Austria", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WKL", "name": "Wolters Kluwer N.V.", "sentiment_url": "https://sharemaestro.com/sentiment/50731efd-0c9a-451d-8506-95bc38ea6fbe/"}]}}]}